Preoperative Lymph Node Staging by FDG PET/CT With Contrast Enhancement for Thyroid Cancer: A Multicenter Study and Comparison With Neck CT
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives. The purpose of this study was to compare lymph node (LN) staging using 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) with contrast-enhancement (CE) PET/CT and contrast-enhanced neck CT (neck CT) in patients with thyroid cancer with level-by-level comparison with various factors. Methods. This was a retrospective multicenter study. A total of 85 patients were enrolled. Patients who underwent a preoperative evaluation by CE PET/CT and neck CT for thyroid cancer were enrolled. The gold standard for LN was the combination of surgical pathology and clinical follow-up. We compared CE PET/CT with neck CT using a level-by-level method. Factors, including age, sex, camera, arm position, tumor size, extra-thyroidal extension, tumor location, number of primary tumors, primary tumor maximum standardized uptake value, and the interval from scan to operation were also analyzed. Results. Overall accuracy was 81.2% for CE PET/CT and 68.2% for neck CT. CE PET/CT was more sensitive than neck CT (65.8% vs. 44.7%). Also, CE PET/CT showed higher negative predictive value (77.2% vs. 66.1%). CE PET/CT showed good agreement with the gold standard (weighted kappa [κ], 0.7) for differentiating N0, N1a, and N1b, whereas neck CT showed moderate agreement (weighted κ, 0.5). CE PET/CT showed better agreement for the number of levels involved with the gold standard (weighted κ, 0.7) than that of neck CT with the gold standard (weighted κ, 0.5). The accuracies for differentiating N0, N1a, and N1b were 81.2% for CE PET/CT and 68.2% for neck CT. Level-by-level analysis showed that CE PET/CT was more sensitive and has higher negative predictive value for detecting ipsilateral level IV and level VI LNs than neck CT. Other analyzed factors were not related to accuracies of both modalities. Conclusion. CE PET/CT was more sensitive and reliable than neck CT for preoperative LN staging in patients with thyroid cancer.
Abstract
Objectives. The purpose of this study was to compare lymph node (LN) staging using 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) with contrast-enhancement (CE) PET/CT and contrast-enhanced neck CT (neck CT) in patients with thyroid cancer with level-by-level comparison with various factors. Methods. This was a retrospective multicenter study. A total of 85 patients were enrolled. Patients who underwent a preoperative evaluation by CE PET/CT and neck CT for thyroid cancer were enrolled. The gold standard for LN was the combination of surgical pathology and clinical follow-up. We compared CE PET/CT with neck CT using a level-by-level method. Factors, including age, sex, camera, arm position, tumor size, extra-thyroidal extension, tumor location, number of primary tumors, primary tumor maximum standardized uptake value, and the interval from scan to operation were also analyzed. Results. Overall accuracy was 81.2% for CE PET/CT and 68.2% for neck CT. CE PET/CT was more sensitive than neck CT (65.8% vs. 44.7%). Also, CE PET/CT showed higher negative predictive value (77.2% vs. 66.1%). CE PET/CT showed good agreement with the gold standard (weighted kappa [κ], 0.7) for differentiating N0, N1a, and N1b, whereas neck CT showed moderate agreement (weighted κ, 0.5). CE PET/CT showed better agreement for the number of levels involved with the gold standard (weighted κ, 0.7) than that of neck CT with the gold standard (weighted κ, 0.5). The accuracies for differentiating N0, N1a, and N1b were 81.2% for CE PET/CT and 68.2% for neck CT. Level-by-level analysis showed that CE PET/CT was more sensitive and has higher negative predictive value for detecting ipsilateral level IV and level VI LNs than neck CT. Other analyzed factors were not related to accuracies of both modalities. Conclusion. CE PET/CT was more sensitive and reliable than neck CT for preoperative LN staging in patients with thyroid cancer.
참고문헌 (24)
- Siegel R, "Cancer statistics, 2012", CA Cancer J Clin, 62(1), pp.10~29 (2012)
- Enewold L, "Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005", Cancer Epidemiol Biomarkers Prev, 18(3), pp.784~791 (2009)
- Dimov RS., "The effect of neck dissection on quality of life in patients with differentiated thyroid cancer", Gland Surg, 2(4), pp.219~226 (2013)
- Adam MA, "Presence and number of lymph node metastases are associated with compromised survival for patients younger than age 45 years with papillary thyroid cancer", J Clin Oncol, 33(21), pp.2370~2375 (2015)
- Stack BC Jr, "American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer", Thyroid, 22(5), pp.501~508 (2012)
- Luster M, "Differentiated thyroid cancer-personalized therapies to prevent overtreatment", Nat Rev Endocrinol, 10(9), pp.563~574 (2014)
- Grant CS., "Papillary thyroid cancer: strategies for optimal individualized surgical management", Clin Ther, 36(7), pp.1117~1126 (2014)
- Kim E, "Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography", Thyroid, 18(4), pp.411~418 (2008)
- Langer JE, "Sonographic imaging of cervical lymph nodes in patients with thyroid cancer", Neuroimaging Clin N Am, 18(3), pp.479~489 (2008)
- Pak K, "The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery", Endocr Relat Cancer, 20(4), pp.R203~R213 (2013)
- Byun BH, "Prediction of central lymph node metastasis from papillary thyroid microcarcinoma by 18F-fluorodeoxyglucose PET", CT and ultrasonography, 2012, pp.26(6), 471~477
- Choi JS, "Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT", AJR Am J Roentgenol, 193(3), pp.871~878 (2009)
- American Joint Committee on Cancer, "AJCC cancer staging manual" (2002), Springer-Verlag
- Som PM., "Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis", AJR Am J Roentgenol, 158(5), pp.961~969 (1992)
- Jeong HS, "Integrated 18F-FDG PET", CT for the initial evaluation of cervical node level of patients with papillary thyroid carcinoma: comparison with ultrasound and contrast-enhanced CT, 2006, pp.65(3), 402~407
- Mitchell JC, "Preoperative evaluation of thyroid nodules with 18FDG-PET", CT, 2005, pp.138(6), 1166~1174
- fluoro-2-deoxy-D-glucose positron emission tomography, "computed tomography in the preoperative assessment of papillary thyroid carcinoma: comparison with sonography", J Ultrasound Med, 30(9), pp.1267~1273 (2011)
- Choi JW, "Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET", CT, 2011, pp.18(5), 1306~1311
- -fluorodeoxyglucose standardized uptake values of PET imaging predict pathologic extrathyroid invasion of thyroid papillary microcarcinomas?, "Laryngoscope", 2006, 2133~2137
- -fluoro-2-deoxy-D-glucose-positron emission tomography, "computed tomography, ultrasonography, and enhanced computed tomography alone in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma", World J Surg, 34(11), pp.2564~2569 (2010)
- Schlumberger M, "Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma", J Clin Endocrinol Metab, 63(4), pp.960~967 (1986)
- Shaha AR, "Differentiated thyroid cancer presenting initially with distant metastasis", Am J Surg, 174(5), pp.474~476 (1997)
- Pryma DA, "Diagnostic accuracy and prognostic value of 18F-FDG PET in Hurthle cell thyroid cancer patients", J Nucl Med, 47(8), pp.1260~1266 (2006)
- Yoneyama T, "Staging accuracy of pancreatic cancer: comparison between non-contrast-enhanced and contrast-enhanced PET", CT, 2014, pp.83(10), 1734~1739